Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is a Phase 3 clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases.